Johnson & Johnson has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke.

Micrus Endovascular will operate under Codman Neurovascular, a business unit of Codman & Shurtleff Inc., the global neurosurgery device company of the DePuy Family of Companies within J&J. Codman Neurovascular and Micrus offer  complementary products and technologies for treating cerebral aneurysms.

The Codman Neurovascular portfolio includes bare platinum coils, vascular reconstruction devices and access devices, and the Micrus portfolio includes enhanced bioactive coil devices, balloon catheters, delivery
systems and stents for the treatment of intracranial stenosis.